 Celcuity Inc NASDAQ: CELC shares are trading higher after the company announced a worldwide licensing agreement with Pfizer Inc. NYSE: PFE to develop and commercialize gedatolisib. Celcuity is a cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. 